← The Wire
NBIXNasdaq
NEUROCRINE BIOSCIENCES INC
Biological Products, (No Diagnostic Substances) · DE · CIK 914475
Neurocrine Biosciences discovers, develops, and commercializes treatments for neurological, psychiatric, endocrine, and immunological disorders
red 8-K · 90d
$16.06B
Market cap
$170.00
Last close
+0.9%
1D
+5.2%
5D
1.4M
Volume
Price · last 39 sessions+26.8%
May 4L $134.07 · H $170.00Jun 29
159
Total filings
May 28, 2026
Last filing
12/31
Fiscal year end
10-K10-KFeb 11, 202610-K10-KFeb 10, 202510-K10-KFeb 9, 202410-K10-KFeb 9, 202310-K10-KFeb 11, 202210-K10-KFeb 5, 202110-K10-KFeb 7, 202010-K10-KFeb 8, 201910-KFORM 10-KFeb 13, 2018
Insider Activity
In the 90 days to Jan 16, 2026: 7 sold $14.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 16, 2026 | Gano KyleChief Executive Officer | Sell | 34,588 | $132.70 | $4.6M |
| Jan 16, 2026 | Gano KyleChief Executive Officer | Sell | 1,812 | $132.71 | $240K |
| Dec 16, 2025 | Norwalk Leslie VDirector | Sell | 1,190 | $155.09 | $185K |
| Dec 15, 2025 | Norwalk Leslie VDirector | Sell | 5,000 | $152.23 | $761K |
| Dec 8, 2025 | Lippoldt DarinChief Legal Officer | Sell | 4,376 | $159.65 | $699K |
| Dec 3, 2025 | Lyons Gary ADirector | Sell | 15,000 | $152.61 | $2.3M |
| Nov 28, 2025 | Benevich EricChief Commercial Officer | Sell | 5,970 | $151.74 | $906K |
| Nov 25, 2025 | Morrow George JDirector | Sell | 15,000 | $143.37 | $2.2M |
| Nov 5, 2025 | Rastetter William HDirector | Sell | 18,000 | $151.82 | $2.7M |
| Nov 4, 2025 | Gano KyleChief Executive Officer | Sell | 300 | $141.97 | $43K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance